These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32852058)

  • 1. The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
    Pillaiyar T; Wendt LL; Manickam M; Easwaran M
    Med Res Rev; 2021 Jan; 41(1):72-135. PubMed ID: 32852058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics.
    Ghosh AK; Brindisi M; Shahabi D; Chapman ME; Mesecar AD
    ChemMedChem; 2020 Jun; 15(11):907-932. PubMed ID: 32324951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivirals for Broader Coverage against Human Coronaviruses.
    Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses.
    Borbone N; Piccialli G; Roviello GN; Oliviero G
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33668428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Santopolo S; Riccio A; Santoro MG
    Biochem Biophys Res Commun; 2021 Jan; 538():80-87. PubMed ID: 33303190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive natural compounds against human coronaviruses: a review and perspective.
    Xian Y; Zhang J; Bian Z; Zhou H; Zhang Z; Lin Z; Xu H
    Acta Pharm Sin B; 2020 Jul; 10(7):1163-1174. PubMed ID: 32834947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
    Leonard RA; Rao VN; Bartlett A; Froggatt HM; Luftig MA; Heaton BE; Heaton NS
    J Virol; 2023 Aug; 97(8):e0059723. PubMed ID: 37578235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective.
    Nile SH; Nile A; Jalde S; Kai G
    Food Chem Toxicol; 2021 Aug; 154():112333. PubMed ID: 34118347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
    Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L
    Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into coronavirus entry.
    Tortorici MA; Veesler D
    Adv Virus Res; 2019; 105():93-116. PubMed ID: 31522710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target.
    Ahmad F; Kamal MA; Tekwani BL
    Curr Pharm Des; 2021; 27(33):3566-3576. PubMed ID: 33327904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside Inhibitors of Coronaviruses.
    Zenchenko AA; Drenichev MS; Mikhailov SN
    Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in the discovery of inhibitors targeting coronavirus proteases.
    Wang H; Xue S; Yang H; Chen C
    Virol Sin; 2016 Feb; 31(1):24-30. PubMed ID: 26920707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the recent progress in Middle East Respiratory Syndrome Coronavirus (MERS-CoV) drug discovery.
    Kandeel M
    Expert Opin Drug Discov; 2023 Apr; 18(4):385-400. PubMed ID: 36971501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
    Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
    Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.
    Wang N; Shang J; Jiang S; Du L
    Front Microbiol; 2020; 11():298. PubMed ID: 32265848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca
    Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.